PLK1 and neoplasm: A single intracerebral injection of CRISPR-LNPs against PLK1 in aggressive orthotopic GB caused tumor cell apoptosis, inhibited tumor growth by 50%, and improved survival by 30% but showed diverse adverse effects [959].